Resultados de la búsqueda filtrada
Los productos de algunos de nuestros proveedores no aparecen en los resultados de la búsqueda filtrada. Por favor,
borre todos los filtros
para ver estos productos.
Resultados de búsqueda de "peprogmp"
1
–
15
de
19
resultados
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human IL-15 |
| Nombre común | IL-15 |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3600 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P40933 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 12.9 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | MNWVNVISDL KKIEDLIQSM HIDATLYTES DVHPSCKVTA MKCFLLELQV ISLESGDASI HDTVENLIIL ANNSLSSNGN VTESGCKECE ELEEKNIKEF LQSFVHIVQM FINTS |
| Alias de gen | AI503618; il 15; Il15; IL-15; ILN; Interleukin; interleukin 15; Interleukin15; interleukin-15; MGC9721; M-IL-15 |
| Actividad biológica | Determined by the proliferation of CTLL-2 cells. PeproGMP Recombinant Human IL-15 ha been tested against the WHO standard NIBSC 95/554. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human IL-7 |
| Nombre común | IL-7 |
| Requisitos de almacenamiento | -20°C or -80°C if preferred |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | Il7, IL7r |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3574, 3575 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P13232, P16871 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 17.4 kDa |
| Secuencia | DCDIEGKDGK QYESVLMVSI DQLLDSMKEI GSNCLNNEFN FFKRHICDAN KEGMFLFRAA RKLRQFLKMN STGDFDLHLL KVSEGTTILL NCTGQVKGRK PAALGEAQPT KSLEENKSLK EQKKLNDLCF LKRLLQEIKT CWNKILMGTK EH |
| Alias de gen | A630026I06Rik; H-IL-7; hlb368; IL7; Il-7; ILN; Interleukin; interleukin 7; Interleukin7; interleukin-7; M-IL-7 |
| Actividad | Determined by the proliferation of mouse 2E8 cells. PeproGMP Recombinant Human IL-7 has been tested against the WHO standard NIBSC 90/530. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human EGF |
| Nombre común | EGF |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | EGF |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 1950 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P01133 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 6.2 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Alias de gen | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Actividad biológica | Determined by the proliferation of mouse Balb/c 3T3 cells. PeproGMP Recombinant Human EGF has been tested against the WHO standard NIBSC 91/530. |
| Actividad | Determined by the proliferation of mouse Balb/c 3T3 cells. PeproGMP Recombinant Human EGF has been tested against the WHO standard NIBSC 91/530. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human LIF |
| Nombre común | LIF |
| Requisitos de almacenamiento | -20°C or -80°C if preferred |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | Lif |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3976 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P15018 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 19.7 kDa |
| Secuencia | SPLPITPVNA TCAIRHPCHN NLMNQIRSQL AQLNGSANAL FILYYTAQGE PFPNNLDKLC GPNVTDFPPF HANGTEKAKL VELYRIVVYL GTSLGNITRD QKILNPSALS LHSKLNATAD ILRGLLSNVL CRLCSKYHVG HVDVTYGPDT SGKDVFQKKK LGCQLLGKYK QIIAVLAQAF |
| Alias de gen | CDF; cholinergic differentiation factor; cholinergic neuronal differentiation factor; d factor; DIA; differentiation inhibitory activity; differentiation-inducing factor; differentiation-stimulating factor; Emfilermin; hepatocyte-stimulating factor III; HILDA; human interleukin in DA cells; leukemia inhibitory factor; leukemia inhibitory factor (cholinergic differentiation factor); LIF; Melanoma-derived LPL inhibitor; MLPLI; myeloid leukaemia inhibitory factor |
| Actividad | Determined by the proliferation of TF-1 cells. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human SCF |
| Nombre común | SCF |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 4254 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P21583 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 18.4 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | MEGICRNRVT NNVKDVTKLV ANLPKDYMIT LKYVPGMDVL PSHCWISEMV VQLSDSLTDL LDKFSNISEG LSNYSIIDKL VNIVDDLVEC VKENSSKDLK KSFKSPEPRL FTPEEFFRIF NRSIDAFKDF VVASETSDCV VSSTLSPEKD SRVSVTKPFM LPPVA |
| Alias de gen | 710-712; blz; c-Kit ligand; Clo; cloud gray; Con; contrasted; CSF; DCUA; DFNA69; DKFZp686F2250; familial progressive hyperpigmentation 2; FPH2; FPHH; Gb; grizzle-belly; hematopoietic growth factor KL; H-SCF; Kit ligand; Kitl; Kitlg; kit-ligand; KL-1; Mast cell growth factor; MGF; M-SCF; Processed kit ligand; SCF; SF; SHEP7; sKITLG; Sl; SLF; Soluble KIT ligand; Steel factor; steel factor/kit ligand; stem cell factor; stem cell factor KL-1; stem cell factor, CSF |
| Actividad biológica | Determined by the proliferation of TF-1 cells. PeproGMP Recombinant Human SCF has been tested against the WHO standard NIBSC 91/682. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human IL-2 |
| Nombre común | IL-2 |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3558 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P60568 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 15.5 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFAQSII STLT |
| Alias de gen | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
| Actividad biológica | Determined by the proliferation of mouse CTLL-2 cells. PeproGMP Recombinant Human IL-2 ha been tested against the WHO standard NIBSC 86/500. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human IL-21 |
| Nombre común | IL-21 |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 59067 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | Q9HBE4 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 15.4 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | MQDRHMIRMR QLIDIVDQLK NYVNDLVPEF LPAPEDVETN CEWSAFSCFQ KAQLKSANTG NNERIINVSI KKLKRKPPST NAGRRQKHRL TCPSCDSYEK KPPKEFLERF KSLLQKMIHQ HLSSRTHGSE DS |
| Alias de gen | CVID11; CX2; il 21; IL21; IL-21; ILN; Interleukin; interleukin 21; Interleukin21; interleukin-21; interleukin-21 isoform; porcine interleukin-21; Za11 |
| Actividad biológica | Determined by the proliferation of ANBL-6 cells. |
| Actividad | Determined by the proliferation of ANBL-6 cells. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human VEGF-165 |
| Nombre común | VEGF-165 |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 7422 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P15692 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 38.2 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Alias de gen | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Actividad biológica | Determined by the proliferation of HUVECs. |
| Actividad | Determined by the proliferation of HUVECs. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human PDGF-AA |
| Nombre común | PDGF-AA |
| Formulación | protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 5154 |
| Concentración de endotoxinas | <0.1 EU/ μg |
| Número de acceso | P04085 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 28.5 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | SIEEAVPAVC KTRTVIYEIP RSQVDPTSAN FLIWPPCVEV KRCTGCCNTS SVKCQPSRVH HRSVKVAKVE YVRKKPKLKE VQVRLEEHLE CACATTSLNP DYREEDTGRP RESGKKRKRK RLKPT |
| Alias de gen | H-PDGF-AA; PDGF A-chain; PDGF subunit A; PDGF1; PDGF-1; Pdgfa; PDGF-A; PDGFACP; platelet derived growth factor subunit A; platelet derived growth factor, alpha; Platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor subunit A; Rpa1 |
| Actividad biológica | Determined by the proliferation of mouse Balb/c 3T3 cells. |
| Actividad | Determined by the proliferation of mouse Balb/c 3T3 cells. |
| Estado normativo | RUO |
| Para utilizar con (aplicación) | Functional Assay |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human IL-3 |
| Nombre común | IL-3 |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3562 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P08700 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 15 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | APMTQTTSLK TSWVNCSNMI DEIITHLKQP PLPLLDFNNL NGEDQDILME NNLRRPNLEA FNRAVKSLQN ASAIESILKN LLPCLPLATA APTRHPIHIK DGDWNEFRRK LTFYLKTLEN AQAQQTTLSL AIF |
| Alias de gen | BP/BPA; BPA; Colony stimulating factor multiple; colony-stimulating factor, multiple; Csfmu; Eo-CSF; HCGF; hematopoietic growth factor; Il3; Il-3; ILN; Interleukin; interleukin 3; Interleukin 3 (colony stimulating factor; Interleukin3; interleukin-3; Mast cell growth factor; mast-cell growth factor; MCGF; MGC79398; MGC79399; MGF; Multi CSF; MULTI-CSF; Multilineage colony stimulating factor; multilineage-colony-stimulating factor; multiple); multipotential colony-stimulating factor; P cell stimulating factor; P-cell stimulating factor; P-cell-stimulating factor; PCSA; PSF |
| Actividad biológica | Determined by the proliferation of TF-1 cells. PeproGMP Recombinant Human IL-3 ha been tested against the WHO standard NIBSC 91/510. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human IL-6 |
| Nombre común | IL-6 |
| Requisitos de almacenamiento | -20°C or -80°C if preferred |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | Il6 |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3569 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P05231 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 20.9 kDa |
| Secuencia | PVPPGEDSKD VAAPHRQPLT SSERIDKQIR YILDGISALR KETCNKSNMC ESSKEALAEN NLNLPKMAEK DGCFQSGFNE ETCLVKIITG LLEFEVYLEY LQNRFESSEE QARAVQMSTK VLIQFLQKKA KNLDAITTPD PTTNASLLTK LQAQNQWLQD MTTHLILRSF KEFLQSSLRA LRQM |
| Alias de gen | B-cell differentiation factor; B-cell hybridoma growth factor; B-cell stimulatory factor 2; BSF2; BSF-2; CDF; CHIL-6; CTL differentiation factor; cytokine; HGF; H-IL-6; HSF; hybridoma growth factor; Ifnb2; IFN-beta-2; Il6; IL-6; ILg6; ILN; interferon beta-2; Interleukin; interleukin 6; Interleukin 6 (interferon, beta 2); interleukin 6 precursor; interleukin BSF-2; interleukin HP-1; Interleukin6; Interleukin-6; interleukin-6 precursor; interleukin-6 protein; M-IL-6; prointerleukin 6; R-IL-6 |
| Actividad | Determined by the proliferation of mouse 7TD1 cells. PeproGMP Recombinant Human IL-6 has been tested against the WHO standard NIBSC 89/548. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human TPO (Thrombopoietin) |
| Nombre común | Thrombopoietin |
| Requisitos de almacenamiento | -20°C or -80°C if preferred |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | THPO |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 7066 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P40225 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 18.6 kDa |
| Secuencia | SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL |
| Alias de gen | C-mpl ligand; Megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; megakaryocyte stimulating factor; Mgdf; MKCSF; ML; MPL ligand; Mpllg; MSA; Myeloproliferative leukemia virus oncogene ligand; prepro-thrombopoietin; TDH2A; THCYT1; THPO; Thrombopoietin; thyroid microsomal antigen; thyroid peroxidase; thyroperoxidase; Tpo; TPX |
| Actividad | Determined by its ability to stimulate human MO7e cell proliferation. PeproGMP Recombinant HumanTPO has been tested against the WHO standard NIBSC 03/124. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human Activin A |
| Nombre común | Activin A |
| Requisitos de almacenamiento | -20°C or -80°C if preferred |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | Inhba |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3624 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P08476 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 26 kDa |
| Secuencia | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| Alias de gen | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Actividad | Determined by the proliferation of mouse MPC-11 cells. PeproGMP Recombinant Human Activin A has been tested against the WHO standard NIBSC 91/626. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human BMP-4 |
| Nombre común | BMP4 |
| Requisitos de almacenamiento | -20°C or -80°C if preferred |
| Tipo de producto | Protein |
| Formulación | Protein with no preservative |
| Método de purificación | Purified |
| Formulario | Lyophilized |
| Símbolo de gen | BMP4 |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 652 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | P12644 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 24.2 kDa |
| Secuencia | MKKNKNCRRH SLYVDFSDVG WNDWIVAPPG YQAFYCHGDC PFPLADHLNS TNHAIVQTLV NSVNSSIPKA CCVPTELSAI SMLYLDEYDK VVLKNYQEMV VEGCGCR |
| Alias de gen | BMP; BMP2B; BMP-2B; Bmp2b1; Bmp2b-1; Bmp4; Bmp-4; BOMPR4A; Bone morphogenetic protein; Bone morphogenetic protein 2B; bone morphogenetic protein 4; bone morphogenetic protein 4 preproprotein; DVR4; Dvr-4; MCOPS6; OFC11; ZYME |
| Actividad | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |
| Sistema de expresión | E. coli |
|---|---|
| Nombre | PeproGMP™ Human Heregulin beta-1 |
| Nombre común | HRG beta-1 |
| Formulación | Protein with no preservative |
| Formulario | Lyophilized |
| Recombinante | Recombinant |
| Conjugado | Unconjugated |
| ID de gen (Entrez) | 3084 |
| Concentración de endotoxinas | ≤0.1 EU/μg |
| Número de acceso | Q02297 |
| Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Peso molecular | 7.5 kDa |
| Formato | Lyophilized |
| Contenido y almacenamiento | -20°Cor to +80°C if preferred |
| Secuencia | SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCPNEF TGDRCQNYVM ASFYKHLGIE FMEAE |
| Alias de gen | 6030402G23Rik; acetylcholine receptor-inducing activity; ARIA; Breast cancer cell differentiation factor p45; D230005F13Rik; GGF; GGF2; GGFII; Glial growth factor; glial growth factor 2; heregulin; heregulin, alpha (45kD, ERBB2 p185-activator); Hgl; HRG; HRG1; HRGA; HRGalpha; MST131; MSTP131; NDF; Neu differentiation factor; neuregulin 1; neuregulin 1 type III beta 3; Neuregulin-1; Nrg1; NRG1-IT2; Pro-neuregulin-1, membrane-bound isoform; pro-NRG1; sensory and motor neuron derived factor; Sensory and motor neuron-derived factor; SMDF; type I neuregulin 1; type III neuregulin 1 |
| Actividad biológica | Determined by proliferation of human MCF-7 cells. |
| Actividad | Determined by proliferation of human MCF-7 cells. |
| Estado normativo | GMP |
| Para utilizar con (aplicación) | Control,Western Blot Control,Bioactivity |